Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2017

Open Access 01-12-2017 | Review article

Caffeine in the management of patients with headache

Authors: Richard B. Lipton, Hans-Christoph Diener, Matthew S. Robbins, Sandy Yacoub Garas, Ketu Patel

Published in: The Journal of Headache and Pain | Issue 1/2017

Login to get access

Abstract

Caffeinated headache medications, either alone or in combination with other treatments, are widely used by patients with headache. Clinicians should be familiar with their use as well as the chemistry, pharmacology, dietary and medical sources, clinical benefits, and potential safety issues of caffeine. In this review, we consider the role of caffeine in the over-the-counter treatment of headache. The MEDLINE and Cochrane databases were searched by combining “caffeine” with the terms “headache,” “migraine,” and “tension-type.” Studies that were not placebo-controlled or that involved medications available only with a prescription, as well as those not assessing patients with migraine and/or tension-type headache (TTH), were excluded. Compared with analgesic medication alone, combinations of caffeine with analgesic medications, including acetaminophen, acetylsalicylic acid, and ibuprofen, showed significantly improved efficacy in the treatment of patients with TTH or migraine, with favorable tolerability in the vast majority of patients. The most common adverse events were nervousness (6.5%), nausea (4.3%), abdominal pain/discomfort (4.1%), and dizziness (3.2%). This review provides evidence for the role of caffeine as an analgesic adjuvant in the acute treatment of primary headache with over-the-counter drugs, caffeine doses of 130 mg enhance the efficacy of analgesics in TTH and doses of ≥100 mg enhance benefits in migraine. Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.
Literature
1.
The International Classification of Headache Disorders (2013) 3rd Edition (beta version). Cephalalgia 33(9):629–808CrossRef
2.
Stovner L et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210CrossRefPubMed
3.
4.
P, M., Socioeconomic costs of headache, in The headaches, O. J, T.-H. P, and W. KMA, Editors. 2000, Lippencott Williams & Wilkins: Philadelphia. p. 33–40
5.
6.
Lipton RB, Newman LC, Solomon S (1994) Over-the-counter medication and the treatment of migraine. Headache 34(9):547–548CrossRefPubMed
7.
J, S. and W. W, Tension-type headache, in Headache, G. PJ and S. SD, Editors. 1997, Butterworth-Heinemann: Boston. p. 177–200
8.
Silberstein, S.D., Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology, 2000. 55(6): p. 754–762
9.
10.
Prior MJ, Codispoti JR, Fu M (2010) A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache 50(5):819–833CrossRefPubMed
11.
Lipton RB et al (2005) Aspirin is efficacious for the treatment of acute migraine. Headache 45(4):283–292CrossRefPubMed
12.
Codispoti JR et al (2001) Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache 41(7):665–679CrossRefPubMed
13.
Kellstein DE et al (2000) Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 20(4):233–243CrossRefPubMed
14.
G, H., et al., Self-medication in migraines and tension headache: evidence-based recommendations of German Migraine and Headache Association (DMKG), German Neurological Society (DGN), the Autrian Headache Association (OKSG) and the Swiss Headache Association (SKG). Nervenheilkunde, 2009. 6: p. 382–397
15.
Frary CD, Johnson RK, Wang MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105(1):110–113CrossRefPubMed
16.
17.
RJ, L., Hawley's Condensed chemical dictionary. 14 ed. 2001, New York: John Wiley & Sons
18.
19.
Ogawa N, Ueki H (2007) Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci 61(3):263–268CrossRefPubMed
20.
Blanchard J, Sawers SJ (1983) The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24(1):93–98CrossRefPubMed
21.
Sawynok J, Yaksh TL (1993) Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 45(1):43–85PubMed
22.
Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176(1):1–29CrossRefPubMed
23.
Fredholm BB et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83–133PubMed
24.
25.
J, S., Adenosine and ATP receptors, in Handbook of experimental pharmacology, S. C, Editor. 2006, Springer: Berlin. p. 301–320
26.
Coney AM, Marshall JM (1998) Role of adenosine and its receptors in the vasodilatation induced in the cerebral cortex of the rat by systemic hypoxia. J Physiol 509(Pt 2):507–518CrossRefPubMedPubMedCentral
27.
Ngai AC et al (2001) Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol Heart Circ Physiol 280(5):H2329PubMed
28.
29.
Fernández-Dueñas V et al (2008) Adjuvant effect of caffeine on acetylsalicylic acid anti-nociception: prostaglandin E2 synthesis determination in carrageenan-induced peripheral inflammation in rat. Eur J Pain 12(2):157–163CrossRefPubMed
30.
Sawynok J (2011) Methylxanthines and pain. Handb Exp Pharmacol 200:311–329CrossRef
31.
32.
33.
Diener HC et al (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25(10):776–787CrossRefPubMed
34.
Diamond S, Balm TK, Freitag FG (2000) Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68(3):312–319CrossRefPubMed
35.
Basurto, O., X, et al., Drug therapy for treating post-dural puncture headache. Cochrane. Database. Syst. Rev, 2011(8): p. CD007887
36.
Halker RB et al (2007) Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth. Neurologist 13(5):323–327CrossRefPubMed
37.
Liang JF, Wang SJ (2014) Hypnic headache: a review of clinical features, therapeutic options and outcomes. Cephalalgia 34(10):795–805CrossRefPubMed
38.
PB B., et al., The effect of caffeine on ibuprofen pharmacokinetics. Acta Pharmacol Toxicol, 1986. 59: p. 54
39.
Price VF, Gale GR (1987) Effects of caffeine on biotransformation and elimination kinetics of acetaminophen in mice. Res Commun Chem Pathol Pharmacol 57(2):249–260PubMed
40.
Yoovathaworn KC, Sriwatanakul K, Thithapandha A (1986) Influence of caffeine on aspirin pharmacokinetics. Eur J Drug Metab Pharmacokinet 11(1):71–76CrossRefPubMed
41.
Godfrey L et al (2006) Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. Eur J Pharmacol 531(1–3):80–86CrossRefPubMed
42.
Sawynok J, Reid AR, Fredholm BB (2008) Caffeine reverses antinociception by amitriptyline in wild type mice but not in those lacking adenosine A1 receptors. Neurosci Lett 440(2):181–184CrossRefPubMed
43.
Tomic MA et al (2004) The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 111(3):253–260CrossRefPubMed
44.
Gayawali K, Pandhi P, Sharma PL (1991) Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. Methods Find Exp Clin Pharmacol 13(8):529–533PubMed
45.
Granados-Soto V et al (1993) Characterization of the analgesic effect of paracetamol and caffeine combinations in the pain-induced functional impairment model in the rat. J Pharm Pharmacol 45(7):627–631CrossRefPubMed
46.
Delzell E, Shapiro S (1998) A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine (Baltimore) 77(2):102–121CrossRef
47.
Lopez JR et al (2006) Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. Eur J Pharmacol 544(1–3):31–38CrossRefPubMed
48.
Po AL, Zhang WY (1998) Analgesic efficacy of ibuprofen alone and in combination with codeine or caffeine in post-surgical pain: a meta-analysis. Eur J Clin Pharmacol 53(5):303–311CrossRefPubMed
49.
Zhang WY, Po AL (1997) Do codeine and caffeine enhance the analgesic effect of aspirin?--a systematic overview. J Clin Pharm Ther 22(2):79–97CrossRefPubMed
50.
Marchand S, Li J, Charest J (1995) Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. N Engl J Med 333(5):325–326CrossRefPubMed
51.
Cabalag MS et al (2010) Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med 17(1):44–49CrossRefPubMed
52.
Horne JA, Reyner LA (1996) Counteracting driver sleepiness: effects of napping, caffeine, and placebo. Psychophysiology 33(3):306–309CrossRefPubMed
53.
Kaplan GB et al (1997) Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37(8):693–703CrossRefPubMed
54.
55.
Silverman K, Mumford GK, Griffiths RR (1994) Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology 114(3):424–432CrossRefPubMed
56.
Doherty M, Smith PM (2004) Effects of caffeine ingestion on exercise testing: a meta-analysis. Int J Sport Nutr Exerc Metab 14(6):626–646CrossRefPubMed
57.
Ganio MS et al (2009) Effect of caffeine on sport-specific endurance performance: a systematic review. J Strength Cond Res 23(1):315–324CrossRefPubMed
58.
Cysneiros RM et al (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther 82(1):54–62CrossRefPubMed
59.
Mitchell PJ, Redman JR (1992) Effects of caffeine, time of day and user history on study-related performance. Psychopharmacology 109(1–2):121–126CrossRefPubMed
60.
Klatsky AL, Armstrong MA, Friedman GD (1993) Coffee, tea, and mortality. Ann Epidemiol 3(4):375–381CrossRefPubMed
61.
Higaki K et al (2008) Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans. Eur J Pharm Biopharm 70(1):313–325CrossRefPubMed
62.
Aurora SK et al (2006) Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 46(1):57–63CrossRefPubMed
63.
Silberstein S (2013) Gastrointestinal manifestations of migraine: meeting the treatment challenges. Headache 53(Suppl 1):1–3CrossRefPubMed
64.
Houghton LA et al (1992) Effect of sumatriptan, a new selective 5HT1-like agonist, on liquid gastric emptying in man. Aliment Pharmacol Ther 6(6):685–691CrossRefPubMed
65.
Malatesta MG et al (2002) 5-HT1-Receptor agonist sumatriptan modifies gastric size after 500 ml of water in dyspeptic patients and normal subjects. Dig Dis Sci 47(11):2591–2595CrossRefPubMed
66.
Sakamoto Y et al (2012) Effect of sumatriptan on gastric emptying: a crossover study using the BreathID system. World J Gastroenterol 18(26):3415–3419CrossRefPubMedPubMedCentral
67.
Tack J et al (1998) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115(6):1346–1352CrossRefPubMed
68.
Vingerhagen S et al (2000) Influence of a 5HT1 receptor agonist on gastric accommodation and initial transpyloric flow in healthy subjects. Neurogastroenterol Motil 12(1):95–101CrossRefPubMed
69.
70.
71.
72.
73.
Lipton RB et al (1998) Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol 55(2):210–217CrossRefPubMed
74.
Migliardi JR et al (1994) Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56(5):576–586CrossRefPubMed
75.
Zhang WY (2001) A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf 24(15):1127–1142CrossRefPubMed
76.
GW, D. and C. DO, Caffeine and the lower esophageal sphincter. Am J Dig Dis, 1972. 7: p. 993–996
77.
Cohen S, Booth GH Jr (1975) Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine. N Engl J Med 293(18):897–899CrossRefPubMed
78.
Eisig JN et al (1989) Coffee drinking in patients with duodenal ulcer and a control population. Scand J Gastroenterol 24(7):796–798CrossRefPubMed
79.
Wendl B et al (1994) Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther 8(3):283–287CrossRefPubMed
80.
Shimamoto T et al (2013) No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One 8(6):e65996CrossRefPubMedPubMedCentral
81.
Michielsen P et al (2009) Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case–control study. Nephrol Dial Transplant 24(4):1253–1259CrossRefPubMed
82.
Feinstein AR et al (2000) Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad hoc Committee of the International Study Group on analgesics and nephropathy. Kidney Int 58(6):2259–2264CrossRefPubMed
83.
84.
Bigal ME et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(8):1157–1168CrossRefPubMed
85.
Di W et al (2013) Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients. Eur J Neurol 20(4):655–662CrossRefPubMed
86.
Bahra A et al (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43(3):179–190CrossRefPubMed
87.
Paemeleire K et al (2006) Medication-overuse headache in patients with cluster headache. Neurology 67(1):109–113CrossRefPubMed
88.
Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41(3):303–309CrossRefPubMed
89.
Zwart JA et al (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 62(9):1540–1544CrossRefPubMed
90.
Dodick D, Freitag F (2006) Evidence-based understanding of medication-overuse headache: clinical implications. Headache 46(Suppl 4):S202–S211CrossRefPubMed
91.
Scher AI, Stewart WF, Lipton RB (2004) Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 63(11):2022–2027CrossRefPubMed
92.
Scher AI et al (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30(3):321–328CrossRefPubMed
93.
Bendtsen L et al (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 17(11):1318–1325CrossRefPubMed
94.
95.
Hughes JR, Hale KL (1998) Behavioral effects of caffeine and other methylxanthines on children. Exp Clin Psychopharmacol 6(1):87–95CrossRefPubMed
96.
Kozlowski LT et al (1993) Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. J Subst Abus Treat 10(2):171–179CrossRef
97.
CP, O.B., Is there an abuse potential for caffein-containing analgesic combinations?, in Advances in the management of acute pain. International Congress and Symposium Series No. 218, H. A, Editor. 2015. p. 11–15
98.
Reissig CJ, Strain EC, Griffiths RR (2009) Caffeinated energy drinks--a growing problem. Drug Alcohol Depend 99(1–3):1–10CrossRefPubMed
99.
M, W., K. Marquardt, and T. Albertson, Adverse effects fro ingestion of Redline Energy Drinks. Clin Toxicol, 2006. 44: p. 642
100.
Iyadurai SJ, Chung SS (2007) New-onset seizures in adults: possible association with consumption of popular energy drinks. Epilepsy Behav 10(3):504–508CrossRefPubMed
101.
Worrall BB, Phillips CD, Henderson KK (2005) Herbal energy drinks, phenylpropanoid compounds, and cerebral vasculopathy. Neurology 65(7):1137–1138CrossRefPubMed
102.
Chrysant SG, Chrysant GS (2015) Cardiovascular complications from consumption of high energy drinks: recent evidence. J Hum Hypertens 29(2):71–76CrossRefPubMed
103.
104.
Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108(1–2):51–59CrossRefPubMed
105.
Griffiths RR, M.G., Caffeine reinforcement, discrimination, tolerance, and physical dependence in laboratory animals and humans, in Pharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach (Handbook of Experimental Pharmacology), S. CR and K. MJ, Editors. 1996, Springer: Berlin, Heidelberg, New York. p. 315–341
106.
107.
Kendler KS, Prescott CA (1999) Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry 156(2):223–228PubMed
108.
109.
Evans SM, Griffiths RR (1999) Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 289(1):285–294PubMed
110.
Couturier EG et al (1997) Influence of caffeine and caffeine withdrawal on headache and cerebral blood flow velocities. Cephalalgia 17(3):188–190CrossRefPubMed
111.
Couturier EG, Hering R, Steiner TJ (1992) Weekend attacks in migraine patients: caused by caffeine withdrawal? Cephalalgia 12(2):99–100CrossRefPubMed
112.
Sousa Melo E (2017) F. Carrilho Aguiar, and P.A. Sampaio Rocha-Filho, Dialysis Headache: A Narrative Review. Headache: The Journal of Head and Face Pain 57(1):161–164CrossRef
113.
Fennelly M, Galletly DC, Purdie GI (1991) Is caffeine withdrawal the mechanism of postoperative headache? Anesth Analg 72(4):449–453CrossRefPubMed
114.
Goldstein J et al (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 46(3):444–453CrossRefPubMed
115.
Pfaffenrath V et al (2009) OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial. Headache 49(5):638–645CrossRefPubMed
116.
Dooley JM et al (2007) Caffeine as an adjuvant to ibuprofen in treating childhood headaches. Pediatr Neurol 37(1):42–46CrossRefPubMed
117.
Yancey JR, Dattoli G (2013) Caffeine as an analgesic adjuvant for acute pain in adults. Am Fam Physician 87(1):11PubMed
Metadata
Title
Caffeine in the management of patients with headache
Authors
Richard B. Lipton
Hans-Christoph Diener
Matthew S. Robbins
Sandy Yacoub Garas
Ketu Patel
Publication date
01-12-2017
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2017
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-017-0806-2

Other articles of this Issue 1/2017

The Journal of Headache and Pain 1/2017 Go to the issue

Research article

Anodal transcranial direct current stimulation over the left temporal pole restores normal visual evoked potential habituation in interictal migraineurs

Research article

The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis

Research article

The comorbidity burden of patients with cluster headache: a population-based study

Research article

Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center

Review article

Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review

Erratum

Erratum to: Psychiatric comorbidities and photophobia in patients with migraine